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A B S T R A C T
Background: A Heart Risk Table has been reported as the ﬁrst risk score based on nuclear cardiology to
predict cardiac event rates in Japanese patients. However, there are no risk scores estimating risk of
major cardiac events (MCEs) except severe heart failure.
Methods: We retrospectively investigated 2579 patients with known or suspected coronary artery
disease (CAD) who underwent rest 201Tl and stress 99mTc-tetrofosmin myocardial perfusion single
photon emission computed tomography between October 2004 and March 2011 and who had data on a
3-year follow-up. The perfusion images were analyzed with 20 segments of a ﬁve-point visual scoring
model to estimate summed defect scores. The endpoint was the onset of MCEs consisting of cardiac
death, non-fatal myocardial infarction and unstable angina pectoris.
Results: During the 3-year follow-up, 171 patients (6.6%) experienced MCEs comprising cardiac death
(n = 78), non-fatal myocardial infarction (n = 30), and unstable angina pectoris (n = 63). The multivariate
logistic regression analysis indicated age, diabetes, estimated glomerular ﬁltration rate (eGFR),
and summed stress scores (SSS) as independent predictors of the MCEs and age, stress ejection fraction,
eGFR, and SSS as independent predictors of cardiac death. Those four predictors and coefﬁcients
corresponding to them were used to make two different risk equations: MCE risk (%/3 years) = 1/
{1 + Exp[(3.176 + 0.018  age + 0.602  diabetes  0.022  eGFR + 0.051  SSS)]}  100 and cardiac
death risk (%/3 years) = 1/{1 + Exp[(2.602 + 0.031  age  0.031  eGFR + 0.038  SSS  0.029  s-
 stress ejection fraction)]}  100.
Conclusion: The risk scores obtained from this study are useful to predict MCEs in Japanese patients with
CAD and are expected to be useful for management and informed consent of high-risk CAD patients.
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.Introduction
Prediction of cardiac event risk is important for determination
of an optimal treatment strategy in patients with coronary artery
disease (CAD). A prediction algorithm developed in an epidemio-
logical study in the USA [1] predicts the risk of CAD over 10 years in
a Caucasian population on the basis of categorical data on sex, age,
low-density lipoprotein (LDL) cholesterol, high-density lipoprotein
(HDL) cholesterol, blood pressure, diabetes mellitus (DM), and* Corresponding author at: Department of Cardiology, Nihon University School of
Medicine, 30-1 Oyaguchi-Kamicho, Itabashi-Ku, Tokyo 173-8610, Japan.
Tel.: +81 3 3972 8111; fax: +81 3 3972 1098.
E-mail address: masteryoda@mf.point.ne.jp (S. Yoda).
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0914-5087/ 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rightssmoking. This algorithm is a highly recommended tool to predict
risk of cardiac events in the Guideline on the Assessment of
Cardiovascular Risk published by American College of Cardiology
and American Heart Association in 2013 [2].
Myocardial perfusion single photon emission computed tomog-
raphy (SPECT) has been well recognized as a useful imaging
methodology for prediction of future cardiac events in patientswith
known or suspected CAD since the reports of Hachamovitch et al.
[3,4]. Also, in Japan,myocardial perfusionSPECThas commonlybeen
used to predict cardiac events in patients with CAD. Risk
stratiﬁcation of cardiac events by nuclear cardiology has been
demonstrated in some large-scale prognostic studies including the
multicenter prospective Japanese Assessment of Cardiac Events and
Survival Study in patients with ischemic heart disease (J-ACCESS)
[5], in asymptomatic patients with type 2 diabetes (J-ACCESS 2) [6],reserved.
S. Yoda et al. / Journal of Cardiology 67 (2016) 64–70 65andpatientswith chronic kidneydisease (CKD) (J-ACCESS3) [7], and
another single-center large-scale prospective study [8].
Nakajima et al. [9] estimated risk of major cardiac events
(MCEs) in Japanese patients with CAD using ﬁve independent
predictors: age, presence of DM, rested left ventricular ejection
fraction (LVEF), summed stress scores (SSS), and estimated
glomerular ﬁltration rate (eGFR) obtained from the J-ACCESS
database (n = 2395). They prepared an equation consisting of the
ﬁve independent predictors and coefﬁcients corresponding to
those to estimate MCEs within 3 years, and published a Heart Risk
Table.
Although this table indicates the ﬁrst risk score based on
nuclear cardiology to predict MCE rates in Japanese patients with
CAD, more than half of the MCEs observed are related to severe
heart failure. In general, MCEs deﬁned in studies outside Japan
[3,4] included no severe heart failure requiring hospitalization
unlike those deﬁned in the J-ACCESS.
We, therefore, have conducted a single-center large-scale
retrospective prognostic study in Japanese patients with CAD
undergoing nuclear cardiology to prepare a formulation providing
risk scores of MCEs excluding severe heart failure during 3 years.
Materials and methods
The institutional review board of Nihon University Itabashi
Hospital approved this study, which proceeded in accordance with
the ethical standards established in the 1964 Declaration of
Helsinki. All study participants provided written informed consent
prior to inclusion in this study.
Patient population
We retrospectively investigated 2579 patients with known or
suspected CAD who underwent rest 201Tl and stress 99mTc-
tetrofosmin myocardial perfusion SPECT [8,10–15] at Nihon
University Itabashi Hospital between October 2004 and March
2011 and who had data on a 3-year follow-up. We excluded
patients aged 20 years, those with hypertrophic or dilated
cardiomyopathy, those with serious valvular heart disease, those
with heart failure being class III or higher New York Heart
Association (NYHA) functional classiﬁcation, those undergoing
revascularization within 90 days after the SPECT, and those having
no baseline eGFR data.
Follow-up examinations were based on medical records for
patients who periodically attended the hospital and responded to
a posted questionnaire for patients who had no periodical visits.
Electrocardiogram-gated dual-isotope myocardial perfusion SPECT
The procedure of rest 201Tl and stress 99mTc-tetrofosmin
electrocardiogram (ECG)-gated myocardial perfusion SPECT was
performed according to a protocol previously reported [8,10–15].
All patients received an intravenous (i.v.) injection of 201Tl
(111 MBq) and a sixteen-frame-gated SPECT image was initiated
10 min after injection during rest. Then an i.v. injection of 99mTc-
tetrofosmin (740 MBq) was performed under stress induced by
ergometer exercise in 27% of the patients or by adenosine
triphosphate in 73% of those. Sixteen-frame-gated SPECT image
acquisition was initiated 30 min after the exercise or 30–60 min
after the adenosine triphosphate stress. The acquisition was
performed in a supine position and subsequently in a prone
position. No attenuation or scatter correction was used. Twelve-
lead ECG was monitored continuously during stress tests. Heart
rate and blood pressure were recorded at baseline and every
minute for at least 3 min after the stress.The projection data over 3608 were obtained with
64  64 matrices and a circular orbit. A triple-detector SPECT
system equippedwith low-energy high-resolution collimatorswas
used (Toshiba, GCA9300A, Tokyo, Japan). SPECT images were
reconstructed from the data with a data processor (Philips North
America, JETStream Workspace 3.0, Andover, MA, USA) combined
with a Butterworth ﬁlter of 201Tl (order 5; cut-off frequency
0.42 cycles/cm), that of 99mTc (order 5; cut-off frequency
0.44 cycles/cm) and a ramp ﬁlter.
SPECT image interpretation
The SPECT images were divided into 20 segments [11] on three
short-axis (distal, mid, basal) and one vertical long-axis (mid)
slices, and the tracer uptake of each segment was visually scored
using a ﬁve-point scale (0: normal; 1: slight reduction of uptake; 2:
moderate reduction of uptake; 3: severe reduction of uptake; and
4: absence of uptake). The sum total of the scores of 20 segments in
the stress and rest images provided the SSS and the summed rest
score (SRS), respectively. The summed difference score (SDS) was
calculated as the difference between the SSS and SRS. Cohen’s
kappa (k), which was calculated to determine the inter-observer
variability for the summed defect score, was 0.92, indicating very
good reproducibility.
Sixteen-frame quantitative-gated SPECT data were analyzed
using QGSTM software (Cedars-Sinai Medical Center, Los Angeles,
CA, USA) to calculate LVEF (%), end-diastolic volume (LVEDV, mL),
and end-systolic volume (LVESV, mL) as described by Germano
et al. [16].
Evaluation of eGFR
TheGFRwas calculated from serum creatinine levels at the time
of SPECT for each patient in the ﬁnal prognostic analysis population
using the Modiﬁcation of Diet in Renal Disease Equation for
Japanese Patients proposed by the Japanese Society of Nephrology
[17] as follows:
eGFR ¼ A 194 ðSerum CreatinineÞ1:094  ðAgeÞ0:287;
where A is 1 formen and 0.739 forwomen and eGFR is expressed as
mL/min/1.73 m2. Patients having eGFR < 60 mL/min/1.73 m2were
diagnosed as having CKD.
Patient follow-up
All patients were followed up for 3 years (36.2  9.7 months)
after the initial stress myocardial perfusion-gated SPECT. The study
endpoint was the onset of MCEs within the 3-year follow-up,
consisting of cardiac death, non-fatal myocardial infarction (MI), and
unstable angina pectoris (UAP) identiﬁed from medical records or
from responses to a posted questionnaire.When a patient had several
cardiac events, only the ﬁrst event was taken as the follow-up
endpoint.
Statistical analysis
Continuous variables were calculated as means and standard
deviations. Intergroup comparisons of continuous variables were
achieved using an unpaired t test. Intergroup comparisons of
categorical variables and global chi-square values were achieved
using the chi-square test. Univariate analyses proceeded using a
Cox proportional hazards model. Multivariate analyses proceeded
using a stepwise Cox proportional hazards model. Multivariate
logistic regression analysis was used to derive equations. All
data were analyzed using MedCalc Software Version 13.1.2.0
S. Yoda et al. / Journal of Cardiology 67 (2016) 64–7066(Mariakerke, Belgium). A p-value of <0.05 was considered
statistically signiﬁcant.
Results
Major cardiac event rates and patient characteristics
During the 3-year follow-up, 171 (6.6%) of 2579 patients
experienced MCEs including cardiac death (n = 78), non-fatal MI
(n = 30), and UAP (n = 63). The cardiac deaths comprised 24 cases
with fatal MI, 22 cases with sudden arrhythmic death, and 32 cases
with congestive heart failure. Table 1 summarizes the character-
istics of the patients with and without MCEs. The proportions of
patients with a typical chest pain, those with a history of MI or
revascularization, and those with hypertension or DM were
signiﬁcantly higher in the group with MCEs than without MCEs
(p < 0.004). The proportion of patients having hyperlipidemia or
smoking habitwas similar between the two groups. The proportion
of patients treated with aspirin, b-blockers, or nitrates was
signiﬁcantly higher in the group with MCEs than without MCEs
(p < 0.003). The proportion of patients treated with other
medications including statins, calcium antagonists, angiotensin
II receptor blockers, or angiotensin-converting enzyme inhibitors
was similar between the two groups with and without MCEs.
Myocardial defect scores (SSS, SRS, and SDS) as well as LVEDV and
LVESV among QGS parameters in both rest and stress images were
signiﬁcantly higher in the group with MCEs than without MCEs
(p < 0.0001). In contrast, LVEF in both rest and stress images and
eGFRs were signiﬁcantly lower in the group with MCEs than
without MCEs (p < 0.0001).Table 1
Characteristics of patients with and without major cardiac events.
Cardiac event
(+)
Cardiac event
()
p-Value
N=171 N=2408
Male patients 127 74.3% 1511 62.7% 0.0033
Age 7110 6810 0.0023
Typical chest pain 31 18.1% 145 6.0% <0.0001
History of MI 64 37.4% 469 19.5% <0.0001
History of
revascularization
77 45.0% 681 28.3% <0.0001
Hypertension 133 77.8% 1679 69.7% 0.0324
Diabetes mellitus 85 49.7% 685 28.4% <0.0001
Hyperlipidemia 84 49.1% 1357 56.4% 0.0783
Smoking 50 29.2% 580 24.1% 0.1546
Aspirin 139 81.3% 1294 53.7% <0.0001
Statins 71 41.5% 1078 44.8% 0.4558
b-Blockers 66 38.6% 663 27.5% 0.0026
Ca-antagonists 88 51.5% 1390 57.7% 0.1286
Nitrates 71 41.5% 576 23.9% <0.0001
ARB 89 52/0% 1117 46.4% 0.1757
ACE inhibitor 23 13.5% 225 9.3% 0.1040
SSS 10.511.0 4.38.2 <0.0001
SRS 5.99.2 2.66.8 <0.0001
SDS 4.65.8 1.73.6 <0.0001
Rest LVEF 55.416.8 63.514.1 <0.0001
Rest LVEDV 96.451.1 77.638.1 <0.0001
Rest LVESV 49.745.9 32.231.2 <0.0001
Stress LVEF 53.816.7 63.014.6 <0.0001
Stress LVEDV 113.358.3 88.841.1 <0.0001
Stress LVESV 60.053.3 37.334.9 <0.0001
eGFR 52.628.0 67.022.9 <0.0001
MI, myocardial infarction; ARB, angiotensin receptor blocker; ACE, angiotensin-
converting enzyme; SSS, summed stress score; SRS, summed rest score; SDS,
summed difference score; LVEF, left ventricular ejection fraction; LVEDV, left
ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume;
eGFR, estimated glomerular ﬁltration rate.Relationship between SSS and MCE rates
The patients were classiﬁed according to SSS grades of normal
(n = 1733), mildly (n = 312), moderately (n = 173), and severely
(n = 361) abnormal. Fig. 1 shows cardiac death and MCE rates
during the 3-year follow-up in each SSS grade group. The cardiac
death rates during 3 years were 1.5%, 2.9%, 3.5%, and 10.2% for
normal, mildly, moderately, and severely abnormal groups,
respectively. The cardiac death rate was signiﬁcantly higher in
the severely abnormal group than in the normal (p < 0.0001) and
mildly (p = 0.0010) and moderately (p = 0.0243) abnormal groups.
The MCE rates during 3 years were 3.7%, 8.0%, 12.1%, and 16.6%
for normal, mildly, moderately and severely abnormal groups,
respectively, being directly proportional to SSS severity. The MCE
rate was signiﬁcantly higher in themildly (p = 0.0012), moderately
(p < 0.0001), and severely (p < 0.0001) abnormal groups than in
the normal group. Statistically signiﬁcant difference in the MCE
rates also was observed between mildly and severely abnormal
groups (p = 0.0012).
The MCE rates were signiﬁcantly higher than the cardiac death
rates in all groups (p< 0.0001 for normal group; p = 0.0082 for
mildly, p = 0.0050 for moderately, and p = 0.0164 for severely
abnormal groups).
Prediction of MCEs
The results of the univariate Cox proportional hazards
regression model analysis showed all demographic and baseline
variables except smoking habit to be signiﬁcant predictors for
MCEs. From those variables, age, DM, SSS, and eGFRwere extracted
as independent predictors for MCEs in multivariate Cox propor-
tional hazards regression model analysis (Table 2).
Table 3 summarizes the results of the univariate and
multivariate Cox proportional hazards regression analyses to
evaluate a predictor for cardiac death. All demographic and
baseline variables except history of revascularization, hyperten-
sion, and smoking habit were signiﬁcant predictors for cardiac
death in the univariate analysis. The results of the multivariate
analysis indicated age, SSS, stress LVEF, and eGFR to be
independent predictors for cardiac death.
Fig. 2 shows changes in global chi-square values for prediction
of MCEs (a) and cardiac death (b) with combination of the
independent predictors identiﬁed by themultivariate analysis. The
[(Fig._1)TD$FIG]
Fig. 1. Rates of cardiac death (open column) and MCE (solid column) during 3 years
stratiﬁed with SSS. *Statistical signiﬁcance vs. normal; **statistical signiﬁcance vs.
normal, mild andmoderate abnormal; ***statistical signiﬁcance betweenMCEs and
cardiac death rates in normal, mild, moderate and severe abnormal. MCEs, major
cardiac events; SSS, summed stress scores.
Table 2
Univariate and multivariate Cox proportional hazards regression analysis for risk of MCE.
Univariate analysis Multivariate analysis
Hazard ratio 95% CI p-Value Hazard ratio 95% CI p-Value
Age 1.0275 1.0110–1.0442 0.0011 1.0200 1.0031–1.0371 0.0208
Male patients 1.7071 1.2137–2.4011 0.0022
Typical chest pain 3.2585 2.2126–4.7988 <0.0001
History of MI 2.3642 1.7372–3.2175 <0.0001
History of Revasc 1.9788 1.4663–2.6703 <0.0001
Hypertension 1.4727 1.0288–2.1080 0.0353
Diabetes mellitus 2.3919 1.7750–3.2231 <0.0001 1.7256 1.2669–2.3503 0.0006
Hyperlipidemia 0.7104 0.5272–0.9573 0.0254
Smoking 1.2797 0.9220–1.7762 0.1424
SSS 1.0562 1.0442–1.0683 <0.0001 1.0485 1.0363–1.0609 <0.0001
SRS 1.0445 1.0301–1.0591 <0.0001
SDS 1.1130 1.0893–1.1373 <0.0001
Rest LVEF 0.9673 0.9592–0.9756 <0.0001
Rest LVEDV 1.0082 1.0056–1.0107 <0.0001
Rest LVESV 1.0097 1.0070–1.0124 <0.0001
Stress LVEF 0.9648 0.9567–0.9729 <0.0001
Stress LVEDV 1.0087 1.0064–1.0109 <0.0001
Stress LVESV 1.0098 1.0074–1.0121 <0.0001
eGFR 0.9743 0.9684–0.9801 <0.0001 0.9785 0.9722–0.9849 <0.0001
MCE, major cardiac event; CI, conﬁdence interval; MI, myocardial infarction; Revasc, revascularization; SSS, summed stress score; SRS, summed rest score; SDS, summed
difference score; LVEF, left ventricular ejection fraction; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; eGFR, estimated
glomerular ﬁltration rate.
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43.4 for age + DM, 89.9 for age + DM + CKD, and 138.9 for
age + DM + CKD + SSS. The global chi-square values for cardiac
death prediction were 10.5 for age, 68.9 for age + CKD, 114.2 for
age + CKD + SSS, and 127.1 for age + CKD + SSS + low EF. Both the
global chi-square values signiﬁcantly increased with the incre-
mental number of independent predictors combined.
Multivariate logistic regression analysis and original cardiac event risk
score
Table 4 summarizes the results of the multivariate logistic
regression analysis for risk of cardiac events in MCE and cardiac
death predicting models. Age, SSS, and eGFR were signiﬁcant
variables in both models. In addition to those, DM and stress LVEF
were signiﬁcant variables in the MCE and cardiac death predicting
models, respectively.Table 3
Univariate and multivariate Cox proportional hazards regression analysis for risk of ca
Univariate analysis
Hazard ratio 95% CI p
Age 1.0403 1.0148–1.0665
Male patients 1.8188 1.0874–3.0422
Typical chest pain 2.0204 1.0438–3.9109
History of MI 1.8216 1.1350–2.9238
History of Revasc 1.1849 0.7418–1.8927
Hypertension 1.6252 0.9407–2.8079
Diabetes mellitus 2.5073 1.6120–3.8999 <
Hyperlipidemia 0.3087 0.1902–0.5011 <
Smoking 1.0558 0.6367–1.7506
SSS 1.0694 1.0529–1.0861 <
SRS 1.0619 1.0437–1.0804 <
SDS 1.1100 1.0759–1.1452 <
Rest LVEF 0.9510 0.9403–0.9618 <
Rest LVEDV 1.0120 1.0090–1.0150 <
Rest LVESV 1.0140 1.0109–1.0171 <
Stress LVEF 0.9486 0.9376–0.9597 <
Stress LVEDV 1.0122 1.0095–1.0150 <
Stress LVESV 1.0137 1.0109–1.0165 <
eGFR 0.9642 0.9560–0.9724 <
CI, conﬁdence interval; MI, myocardial infarction; Revasc, revascularization; SSS, summ
ventricular ejection fraction; LVEDV, left ventricular end-diastolic volume; LVESV, leOn the basis of the four predictors and coefﬁcients correspond-
ing to them, the MCE risk per 3 years was calculated as follows:
MCE risk ð%=3yearsÞ
¼ 1
1þ Exp½ð3:176þ 0:018 ageþ 0:602 DM
 0:022 eGFR þ 0:051 SSSÞ
 100:
Likewise, the cardiac death risk per 3 years was calculated as
follows:
Cardiac death risk ð%=3yearsÞ
¼ 1
1þ Exp½ð2:602þ 0:031 age 0:031 eGFR
þ 0:038 SSS 0:029 stress ejection fractionÞ
 100;
where age is given as years, DM is 1 for presence or 0 for absence,
eGFR as mL/min/1.73 m2, SSS as continuous variables, and EF as %.rdiac death.
Multivariate analysis
-Value Hazard ratio 95% CI p-Value
0.0019 1.0344 1.0090–1.0605 0.0079
0.0233
0.0379
0.0134
0.4800
0.0833
0.0001
0.0001
0.8342
0.0001 1.0330 1.0103–1.0561 0.0043
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001 0.9678 0.9514–0.9844 0.0002
0.0001
0.0001
0.0001 0.9703 0.9611–0.9795 <0.0001
ed stress score; SRS, summed rest score; SDS, summed difference score; LVEF, left
ft ventricular end-systolic volume; eGFR, estimated glomerular ﬁltration rate.
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Fig. 2. Changes in global chi-square values for prediction of major cardiac events (a)
and cardiac death (b) with combination of the independent predictors identiﬁed by
the multivariate analysis. DM, diabetes mellitus; CKD, chronic kidney disease; SSS,
summed stress scores; EF, ejection fraction.
Table 4
Multivariate logistic regression analysis for risk of cardiac events.
Coefﬁcient Standard error
(a) MCE predicting model
Age 0.018 0.0090
Diabetes mellitus 0.602 0.1686
eGFR 0.022 0.0035
SSS 0.051 0.0070
Constant 3.176
(b) Cardiac death predicting model
Age 0.031 0.0132
eGFR 0.031 0.0050
SSS 0.038 0.0125
Stress LVEF 0.029 0.0092
Constant 2.602
MCE, major cardiac event; CI, conﬁdence interval; eGFR, estimated glomerular ﬁltrat
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This is the ﬁrst report demonstrating an original risk score for
prediction ofMCEs except severe heart failure, whichwas prepared
on the basis of the results from the retrospective large-scale cohort
study in Japanese patients with known or suspected CAD. With
respect to risk scores predicting prognosis in Japanese patients
with CAD, the Heart Risk Table based on the J-ACCESS database has
been reported to be useful to predict risk of MCEs including severe
heart failure within 3 years [9].
However, severe heart failure is generally excluded from MCEs
in prognostic studies in Europe and the USA because the criteria for
hospitalization of patients with severe heart failure are varied
among medical institutes unlike for patients with acute coronary
syndrome. Therefore, the equations derived from the results of the
present study are considered to be useful to estimate risk of MCEs
except severe heart failure in Japanese patients with CAD.
In the present study, the results from multivariate analysis
indicated that the independent predictors for risk ofMCEswere not
same as those for risk of cardiac death. Although the common
predictors between MCEs and cardiac death were age, eGFR, and
SSS, risk of MCEs increased in the presence of DM while risk of
cardiac death did in the reduction of stress LVEF. It is easily
understood that risk of MCEs resulting from acute coronary
syndrome increased in patients having concurrent DM and risk of
cardiac death did in patients having left ventricular dysfunction.
Combination of the four predictors each led to a signiﬁcant rise of
global chi-square values resulting in improvement of predictive
precision for MCEs or cardiac death. On the basis of these results,
we have created two different equations using the four indepen-
dent parameters to precisely predict risk of cardiac death or MCEs
except severe heart failure during 3 years.
Risk of cardiac death and MCEs within 3 years was signiﬁcantly
higher in this study than in J-ACCESS [5] (3.0% vs. 1.1%,
p < 0.0001 and 6.6% vs. 2.0%, p < 0.0001, respectively). In addition,
risk of the MCEs in the normal group with SSS3 was signiﬁcantly
higher in this study than in J-ACCESS (3.7% vs. 1.4%, p < 0.0001).
The patients enrolled in this study are considered to be a high-risk
population in comparison with those in J-ACCESS. Because
retrospective data collected in a core university hospital are likely
to include most of those obtained from high-risk patients, these
differences may result from selection bias. The severity of CAD in
patients enrolled in J-ACCESS was relatively low because of the
inter-site variation of inclusion criteria for the pre-test likelihood
and severity of CAD. Cardiac event rates reported in J-ACCESS were
a half for MCEs and a quarter for cardiac death in comparison with
those reported in studies in the USA [3,5].
A predictive equation in the Heart Risk Table that Nakajima
et al. [9] created using the J-ACCESS database is based on similarOdds ratio 95% CI p-Value
1.0179 1.0001–1.0360 0.0490
1.8271 1.3128–2.5428 0.0004
0.9787 0.9719–0.9855 <0.0001
1.0526 1.0382–1.0672 <0.0001
1.0318 1.0053–1.0590 0.0185
0.9698 0.9602–0.9796 <0.0001
1.0392 1.0140–1.0649 0.0021
0.9710 0.9537–0.9885 0.0013
ion rate; SSS, summed stress score; LVEF, left ventricular ejection fraction.
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odds ratio for DM was also similar between the Heart Risk
Table and the result from our predictive equation; risk of MCEs
increased by 2.2-fold and 1.8-fold, respectively, due to concurrent
DM. However, MCEs deﬁned in J-ACCESS consisted of cardiac
death, non-fatal MI, and severe heart failure and the proportion of
severe heart failure was 55.2% (64/116). Therefore, the Heart Risk
Table is a suitable model to predict risk of severe heart failure but
might be inapplicable for prediction of risk of acute coronary
syndrome.
In addition, the Heart Risk Table is limited to prediction of risk
of total events and is unable to predict separately risk of MCEs
and cardiac death because the total number of MCEs was small.
Furthermore, the Heart Risk Table has an issue of the absence of
the detailed data on severity obtained from nuclear cardiology,
because QGS data were obtained only at rest not at stress and SSS
was handled as a nonparametric variable of high or low but not as
a continuous variable. In Japan, there is another risk model and
calculator (Japan Score), which was created in 2008 on the basis
of Japan Cardiovascular Surgery Database accumulated from
2000 [18]. The Japan Score is useful to predict risk of early death
after cardiac surgery, but is not able to be applied to risk
estimation of future MCEs after treatment in Japanese patients
with CAD.
In the USA, Hachamovitch et al. created a prognostic adenosine
score on the basis of the data obtained from adenosine stress SPECT
performed in more than 2000 patients [19]. This score is useful to
predict cardiovascular mortality and treatment beneﬁt within
2 years on the basis of 10 variables including age, % myocardium
ischemia, DM, and rest and peak heart rates. This was the ﬁrst risk
score based on variables obtained from nuclear cardiology but has
never been widespread because it is complicated for use in clinical
practice. On the other hand, a risk score obtained from the
Framingham Heart Study [1] is well known as a risk score in CAD
patients and is able to estimate risk of CAD within 10 years on the
basis of data on sex, age, LDL-C, HDL-C, blood pressure, DM, and
smoking habit. This risk score has been highly recommended by
2013 ACC/AHA Guideline on the Assessment of Cardiovascular
Risk [2]. There are also risk factors derived from atherosclerosis
imaging, including ankle-brachial index, coronary artery calcium,
and carotid intima-media thickness, but predictive signiﬁcance
of those factors has not been yet clariﬁed even in the results from
a meta-analysis study [20–22].
In Europe, there is a famous risk score for cardiac disease (Euro
Score), which is useful to predict risk of death within 30 days after
cardiac surgery and is widely used to estimate an early death rate
after coronary artery bypass grafting [23,24].
Establishment of tools predicting exact risk of future serious
events is essential for today’s medical practices in the world. Our
risk score obtained from the present study is able to predict risk of
MCEs before decision to perform percutaneous coronary interven-
tion and/or effective therapies andmay be applied to estimation of
a risk reduction after the intervention and/or therapies. However,
before the application, a future study should be designed to
validate the prognostic accuracy of the risk score.
Limitations of this study
The limitation of this study is that our risk score, which was
created on the basis of data from a retrospective single-center
investigation,may involve selection bias. However, our risk score is
able to predict risk of MCEs except severe heart failure and is able
to be applied to high-risk patients with CAD unlike the Heart Risk
Table currently available in Japan. In addition, this risk score is a
tool that is easily used in any other institutes because it is easily
calculated with general spreadsheet software.Also, radiation exposure from cardiac imaging has become a
recent important topic. The radiation exposure to the patients from
the 201Tl + 99mTc-tetrofosmin dual-isotope SPECT in this study was
nearly 30 mSv,whichwas higher than that from 99mTc-tetrofosmin
rest-stress SPECT (8.6 mSv) [25,26]. However, the reasons why we
used this protocol were that patients were not restricted for a
long time because of the short procedural length and that the
results of the imaging were informed to the patient immediately
after the procedure completion. Our risk score is expected to be
possibly applied to the 99mTc-tetrofosmin rest-stress SPECT
protocol because prediction of prognosis or diagnostic accuracy
with 201TI is generally similar to that with 99mTc-tetrofosmin [27].
In conclusion, the risk scores obtained from this study are useful
to predict MCEs in Japanese patients with known or suspected CAD
and are expected to be useful for management and informed
consent of high-risk patients with CAD whom we meet in daily
clinical practice.
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